Alto Neuroscience, Inc. logo

ANROAlto Neuroscience, Inc.

ANRO Stock Price, Valuation & Chart | Alto Neuroscience, Inc.

Compare

ANRO Historical price chart

ANRO Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization1.29B
PE Ratio-15.14
EPS-2.42
Trading Volume432.76K
Today's High/Low37.39/35.22
Dividend Yield0.00
52 Week High/Low37.48/3.41
Shares Outstanding35.09M
ANRO Financial Statement
ANRO Analyst ratings
ANRO Analysis & performance metrics

ANRO Company profile

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company develops ALTO-100 for the…

ANRO Management team

Management
Jessica Powell
Chief Development Officer
Nicholas C. SmithCFO
Chief Financial Officer & Chief Business Officer
Michael C. Hanley M.B.A.COO
Chief Operating Officer
Amit Etkin M.D., Ph.D.CEO
Founder, Chairman of the Board, Chief Executive Officer & President
Dan Segal B.Sc. (Hons), BCom, CA, MSc
Co-Founder & Strategic Advisor
Erin R. McQuade J.D.
General Counsel, Chief Administrative Officer & Corporate Secretary
Adam Savitz M.D., Ph.D.
Chief Medical Officer
Total 7 executives

ANRO Frequently asked questions

What is Alto Neuroscience, Inc. (ANRO) Stock Price?

Current stock price of Alto Neuroscience, Inc. (ANRO) stock is $36.640. The stock price is +4.09% higher in the session. The intraday range can be seen from this page. Volume of Alto Neuroscience, Inc. (ANRO) stock is 432.76K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Alto Neuroscience, Inc. (ANRO) stock price going up or down today?

The stock price of Alto Neuroscience, Inc. (ANRO) can change with earnings, company news, and overall market sentiment. Alto Neuroscience, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Alto Neuroscience, Inc. stock expensive at its current price?

Whether Alto Neuroscience, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ANRO on this page is -15.14. EPS on this page is -2.42. Compare those figures with peers and growth expectations before deciding if the current Alto Neuroscience, Inc. price is justified.

How has the stock price of Alto Neuroscience, Inc. (ANRO) performed historically?

Historical performance for Alto Neuroscience, Inc. (ANRO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ANRO reacted to past earnings and market events.

Should I buy Alto Neuroscience, Inc. (ANRO) stock, at this price?

Buying Alto Neuroscience, Inc. (ANRO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.